Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -28.15% is 31% above its 5-year average of -40.82%, near the high end of its 5-year range (-102.08%–-23.31%).
As of the fiscal period ended Tuesday, June 30, 2026. 45.22% above its 12-month average of -51.39%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -28.15%.
RETURN ON INVESTED CAPITAL (ROIC)
-28.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-51.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-42.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-40.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-40.90%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+45.22%
CURRENT VS 3Y AVG
+33.46%
CURRENT VS 5Y AVG
+31.05%
CURRENT VS 10Y AVG
+31.17%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+21.03%
vs the sector median at left
Celcuity Inc.
Market Cap
$3.49B
Return on Invested Capital (ROIC)
-28.15%
TTM Avg
-51.39%
3Y Avg
-42.30%
5Y Avg
-40.82%
Market Cap
$3.49B
Return on Invested Capital (ROIC)
-17.68%
TTM Avg
-22.74%
3Y Avg
-21.16%
5Y Avg
-18.86%
Market Cap
$3.53B
Return on Invested Capital (ROIC)
-12.91%
TTM Avg
-40.91%
3Y Avg
-35.75%
5Y Avg
-31.17%
Market Cap
$3.51B
Return on Invested Capital (ROIC)
-35.27%
TTM Avg
-38.13%
3Y Avg
-29.19%
5Y Avg
-24.81%
Market Cap
$3.44B
Return on Invested Capital (ROIC)
-79.40%
TTM Avg
-65.84%
3Y Avg
-73.62%
5Y Avg
-96.54%
Market Cap
$3.55B
Return on Invested Capital (ROIC)
6.72%
TTM Avg
3.30%
3Y Avg
-1.32%
5Y Avg
-3.44%
Market Cap
$3.56B
Return on Invested Capital (ROIC)
-1.07%
TTM Avg
-9.16%
3Y Avg
-22.10%
5Y Avg
-20.63%
Market Cap
$3.39B
Return on Invested Capital (ROIC)
6.25%
TTM Avg
16.80%
3Y Avg
-7.33%
5Y Avg
-16.60%
Market Cap
$3.38B
Return on Invested Capital (ROIC)
-0.93%
TTM Avg
1.17%
3Y Avg
-16.63%
5Y Avg
-13.35%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Celcuity Inc. (CELC) | $3.49B | -28.15% | -51.39% | -42.30% | -40.82% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.49B | -17.68% | -22.74% | -21.16% | -18.86% |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.53B | -12.91% | -40.91% | -35.75% | -31.17% |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.51B | -35.27% | -38.13% | -29.19% | -24.81% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | -79.40% | -65.84% | -73.62% | -96.54% |
| Veracyte, Inc. (VCYT)vs › | $3.55B | 6.72% | 3.30% | -1.32% | -3.44% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.56B | -1.07% | -9.16% | -22.10% | -20.63% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.39B | 6.25% | 16.80% | -7.33% | -16.60% |
| CareDx, Inc (CDNA)vs › | $3.38B | -0.93% | 1.17% | -16.63% | -13.35% |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.33B | -409.85% | -257.76% | -257.76% | -257.76% |
ROIC
-28.1%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -28.15% |
| 2026-03-31 | -49.49% |
| 2025-12-31 | -40.76% |
| 2025-09-30 | -36.46% |
| 2025-06-30 | -102.08% |
| 2025-03-31 | -68.52% |
| 2024-12-31 | -53.08% |
| 2024-09-30 | -39.14% |
| 2024-06-30 | -31.28% |
| 2024-03-31 | -44.42% |
| 2023-12-31 | -37.41% |
| 2023-09-30 | -44.84% |
| 2023-06-30 | -34.07% |
| 2023-03-31 | -27.93% |
| 2022-12-31 | -23.31% |
| 2022-09-30 | -58.10% |
| 2022-06-30 | -42.56% |
| 2022-03-31 | -43.30% |
| 2021-12-31 | -34.00% |
| 2021-09-30 | -27.62% |
| 2021-06-30 | -52.01% |
| 2021-03-31 | -28.52% |
| 2020-12-31 | -81.18% |
| 2020-09-30 | -63.26% |
| 2020-06-30 | -53.64% |
| 2020-03-31 | -46.45% |
| 2019-12-31 | -40.30% |
| 2019-09-30 | -37.73% |
| 2019-06-30 | -34.33% |
| 2019-03-31 | -32.55% |
| 2018-12-31 | -31.27% |
| 2018-09-30 | -28.98% |
| 2018-06-30 | -25.81% |
| 2018-03-31 | -23.50% |
| 2017-12-31 | -18.96% |
| 2017-09-30 | -15.35% |
| 2017-06-30 | -40.19% |
| 2017-03-31 | -76.32% |
| 2016-12-31 | -59.31% |
